Acquired MET Y1248H and D1246N mutations mediate resistance to MET inhibitors in non–small cell lung cancer

Anna Li, Jin Ji Yang, Xu Chao Zhang, Zhou Zhang, Jian Su, Lan Ying Gou, Yu Bai, Qing Zhou, Zhenfan Yang, Han Han-Zhang, Wen Zhao Zhong, Shannon Chuai, Qi Zhang, Zhi Xie, Hongfei Gao, Huajun Chen, Zhen Wang, Zheng Wang, Xue Ning Yang, Bin Chao WangBin Gan, Zhi Hong Chen, Ben Yuan Jiang, Si Pei Wu, Si Yang Liu, Chong Rui Xu, Yi Long Wu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Acquired MET Y1248H and D1246N mutations mediate resistance to MET inhibitors in non–small cell lung cancer'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science